From FT yesterday.Need to a subscriber for the rest.
Obesity treatment trial data is tonic for Alizyme
By Lisa Urquhart,
Published: December 13 2005 02:00 | Last updated: December 13 2005 02:00
Alizyme's market capitalisation gained a few pounds yesterday after the group reported positive trial data for its obesity treatment.
The Cambridge-based group yesterday said that its product Cetilistat compared favourably with the leading drug on the market and caused fewer side effects